OptiBiotix Health (LON:OPTI) Stock Price Down 10.6% – Should You Sell?

OptiBiotix Health Plc (LON:OPTI) shares fell 10.6% during trading on Wednesday. The stock traded as low as GBX 4.55 and last traded at GBX 4.56. 537,026 shares traded hands during mid-day trading, an increase of 72% from the average session volume of 311,584 shares. The stock had previously closed at GBX 5.10.

OptiBiotix Health Price Performance

The firm’s fifty day simple moving average is GBX 5.78 and its 200 day simple moving average is GBX 5.85. The company has a market capitalization of £4.70 million, a price-to-earnings ratio of -1.08 and a beta of 1.82.

OptiBiotix Health (LON:OPTI) last released its quarterly earnings results on Thursday, September 17th. The company reported GBX (1.52) earnings per share (EPS) for the quarter. OptiBiotix Health had a negative net margin of 332.69% and a negative return on equity of 77.85%.

About OptiBiotix Health

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness. OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.